Therapeutic advances in COVID-19 | Nature Reviews Nephrology
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection - The American Journal of Medicine
Full article: Low-dose aspirin for early COVID-19: does the early bird catch the worm?
Rationales and uncertainties for aspirin use in COVID-19: a narrative review | Family Medicine and Community Health
The effects of aspirin on the outcome of COVID-19: A systematic review and meta-analysis - Clinical Epidemiology and Global Health
Full article: Low-dose aspirin for early COVID-19: does the early bird catch the worm?
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 Registry | Journal of the American Heart Association
A guide to immunotherapy for COVID-19 | Nature Medicine
Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis | SpringerLink
Rapid implementation of mobile technology for real-time epidemiology of COVID-19 | Science
Pre-hospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS) | Archivos de Bronconeumología
Could aspirin intake reduce mortality risk in COVID-19 patients?
Neurology International | Free Full-Text | Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities
Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence- - International Journal of Cardiology
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents - The Lancet Infectious Diseases
Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates - ScienceDirect
Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico - International Journal of Infectious Diseases
Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients? - Federico Cacciapuoti, Fulvio Cacciapuoti, 2021
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation | Nature Reviews Cardiology
Biomedicines | Free Full-Text | Aspirin and Infection: A Narrative Review
Methods and Protocols in COVID-19 Research, Diagnostic and Treatment | Biology Methods and Protocols | Oxford Academic
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry | Heart
Post-acute COVID-19 syndrome | Nature Medicine
COVID-19 therapeutics: Challenges and directions for the future | PNAS
